ARGENT BIOPHARMA LIMITED

ASX: RGT
Sector
Sector:Health Care
Industry group
Industry:Pharmaceuticals, Biotechnology & Life Sciences

RGT Share Price

RGT News & Analysis

RGTHealth CareCompany Update29 Sept 2026· 2 min read

Argent BioPharma (ASX: RGT) Licences NLC Antiviral Portfolio

Argent BioPharma has licensed commercial rights to NLC’s Tollovir, Tollovid and NutraVir antiviral applications. The deal includes US$300,000 in scheduled base fees, tiered royalties and sales-linked consideration.

Latest RGT ASX Announcements

  1. 20 Nov 2026 · 1:27 pmMeetings & Governance
  2. 11 Nov 2026 · 2:48 pmSubstantial Holders
  3. 23 Oct 2026 · 8:15 amQuarterly Reports
  4. 19 Oct 2026 · 8:07 amMeetings & Governance
  5. 14 Oct 2026 · 3:39 pmMeetings & Governance
  6. 12 Oct 2026 · 9:41 amCompany Update
  7. 2 Oct 2026 · 5:57 pmSecurities Administration
  8. 1 Oct 2026 · 8:48 amCapital Raising
  9. 29 Sept 2026 · 8:42 amSecurities Administration
  10. 29 Sept 2026 · 8:40 amCompany Update
  11. 1 Sept 2026 · 6:06 pmSecurities Administration
  12. 31 Aug 2026 · 5:23 pmFinancial Results
  13. 31 Aug 2026 · 5:20 pmCompany Administration
View complete RGT announcement history →